# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-029435
Filing Date
2022-08-12
Accepted
2022-08-12 16:16:51
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | ny20004814x5_defa14a.htm | DEFA14A | 7963
2 |  | ny20004814x5_nc01.jpg | GRAPHIC | 1678083
3 |  | ny20004814x5_nc02.jpg | GRAPHIC | 1531714
| Complete submission text file | 0001140361-22-029435.txt |  | 4431098

Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-11460 | Film No.: 221160330
SIC: 2834 Pharmaceutical Preparations